Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Circular RNA Cdr1as inhibits proliferation and delays injury-induced regeneration of the intestinal epithelium
Hee Kyoung Chung, Lan Xiao, Naomi Han, Jason Chen, Vivian Yao, Cassandra M. Cairns, Benjamin Raufman, Jaladanki N. Rao, Douglas J. Turner, Rosemary Kozar, Myriam Gorospe, Jian-Ying Wang
Hee Kyoung Chung, Lan Xiao, Naomi Han, Jason Chen, Vivian Yao, Cassandra M. Cairns, Benjamin Raufman, Jaladanki N. Rao, Douglas J. Turner, Rosemary Kozar, Myriam Gorospe, Jian-Ying Wang
View: Text | PDF
Research Article Gastroenterology

Circular RNA Cdr1as inhibits proliferation and delays injury-induced regeneration of the intestinal epithelium

  • Text
  • PDF
Abstract

Circular RNAs (circRNAs) are highly expressed in the mammalian intestinal epithelium, but their functions remain largely unknown. Here, we identified the circRNA Cdr1as as a repressor of intestinal epithelial regeneration and defense. Cdr1as levels increased in mouse intestinal mucosa after colitis and septic stress, as well as in human intestinal mucosa from patients with inflammatory bowel disease and sepsis. Ablation of the Cdr1as locus from the mouse genome enhanced renewal of the intestinal mucosa, promoted injury-induced epithelial regeneration, and protected the mucosa against colitis. We found approximately 40 microRNAs, including miR-195, differentially expressed between intestinal mucosa of Cdr1as-knockout (Cdr1as–/–) versus littermate mice. Increasing the levels of Cdr1as inhibited intestinal epithelial repair after wounding in cultured cells and repressed growth of intestinal organoids cultured ex vivo, but this inhibition was abolished by miR-195 silencing. The reduction in miR-195 levels in the Cdr1as–/– intestinal epithelium was the result of reduced stability and processing of the precursor miR-195. These findings indicate that Cdr1as reduces proliferation and repair of the intestinal epithelium at least in part via interaction with miR-195 and highlight a role for induced Cdr1as in the pathogenesis of unhealed wounds and disrupted renewal of the intestinal mucosa.

Authors

Hee Kyoung Chung, Lan Xiao, Naomi Han, Jason Chen, Vivian Yao, Cassandra M. Cairns, Benjamin Raufman, Jaladanki N. Rao, Douglas J. Turner, Rosemary Kozar, Myriam Gorospe, Jian-Ying Wang

×

Figure 2

Targeted deletion of the Cdr1as locus by CRISPR/Cas9 promotes renewal of the intestinal epithelium and enhances gut barrier function in mice.

Options: View larger image (or click on image) Download as PowerPoint
Targeted deletion of the Cdr1as locus by CRISPR/Cas9 promotes renewal of...
(A) The sequences given denote protospacer-adjacent motifs. kb, kilobases. (B) Q-PCR assay confirmed successful genetic ablation of Cdr1as, as shown by a specific decrease in levels of Cdr1as in the small intestinal mucosa of Cdr1as–/– mice. Values are the mean ± SEM (n = 3 or 5). *P < 0.05 compared with littermates. (C) Left: Proliferating cells in small intestinal crypts in control littermate and Cdr1as–/– mice, as measured by Ki67 immunostaining. Red, Ki67; green, E-cadherin (E-cad). Right: Quantitative data of Ki67-positive cells (n = 10). *P < 0.05 compared with littermates. (D) Photomicrographs of H&E (left) and changes in the length of villi and crypts (right) of the mucosa described in C (n = 10). *P < 0.05 compared with littermates. (E–G) Changes in Paneth cells (lysozyme-positive cells), goblet cells (Alcian blue staining), and tuft cells (DCLK1-positive cells) in the mucosa described in C. *P < 0.05 compared with littermates (n = 10). (H) Changes in gut permeability in littermate and Cdr1as–/– mice. FITC-dextran was given orally, and blood samples were collected 4 hours thereafter for measurement. *P < 0.05 compared with littermates (n = 6). In B–H, statistical significance was analyzed using unpaired, 2-tailed Student’s t tests. Scale bars: 25 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts